P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12 DIRECT STUDY BASED ON TROUGH LEVELS MINIMISE TOXICITY AND PRESERVE EFFICACYDavid T Yeung, Timothy P. Hughes, Deborah L. White et al.|HemaSphere|2022Cited by 1
The <scp>PINNACLE</scp> study: A multicentre phase <scp>II</scp> trial of nilotinib in combination with pegylated interferon‐α2b in newly diagnosed chronic phase chronic myeloid leukaemiaDavid T. Yeung, the Australasian Leukaemia and Lymphoma Group, Andrew P. Grigg et al.|British Journal of Haematology|2025Cited by 1